Facilitated By

San Antonio Medical Foundation

News

  • REVEAL GENOMICS Presents the Latest HER2DX® Data in HER2+ Breast Cancer at SABCS 2022

    SAN ANTONIO, Texas, December 06, 2022--REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize precision oncology ...

  • Level One Evidence Proves Premenopausal Patients within the Ultra-Low Subset of ... - BioSpace

    AMSTERDAM--(BUSINESS WIRE)-- At the 2022 San Antonio Breast Cancer Symposium (SABCS), Agendia, Inc., a leader in breast cancer gene expression ...

  • In search for next-gen Covid treatment, Pfizer taps tiny biotech for research deal

    Eisai and METAvivor plan to debut the latest 'This is MBC' campaign at the San Antonio Breast Cancer Symposium (SABCS).

  • Verge Genomics Appoints Diego Cadavid, M.D., as Chief Medical Officer | BioSpace

    ... a clinical-stage, tech-enabled biotechnology company pioneering the use of ... of Texas Health Science Center in San Antonio, Texas (UTHSCSA), ...

  • "Step Into STEM"...and the workforce - WOAI

    San Antonio's East side is becoming one of the biggest hubs for bioscience and technology.